News
Feed
Events
Feed
News
+ Events
Feed

Heidelberg Pharma AG

  • ISIN DE000A11QVV0
  • Country Deutschland

Latest News

1 October 2024

17:29 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient

15:27 Ad-hoc

Heidelberg Pharma AG

Ad-hoc

Heidelberg Pharma AG Announces Updated Guidance

23 September 2024

13:05 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024

29 August 2024

13:14 Directors’ Dealings

Heidelberg Pharma AG

Directors’ Dealings

Heidelberg Pharma AG: Walter Miller, buy

13:03 Directors’ Dealings

Heidelberg Pharma AG

Directors’ Dealings

Heidelberg Pharma AG: Walter Miller, buy

27 August 2024

11:22 Directors’ Dealings DE

Heidelberg Pharma AG

Directors’ Dealings
DE

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Annahme der Gewährung von 75.000 Aktienoptionen im Rahmen des Aktienoptionsprogramms 2023 für Mitarbeiter und Vorstandsmitglieder der Heidelberg …

11 July 2024

07:05 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business

21 June 2024

11:16 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma reports on the results of the Annual General Meeting 2024

18 June 2024

13:47 Ad-hoc

Heidelberg Pharma AG

Ad-hoc

Heidelberg Pharma AG announces updated guidance

23 May 2024

09:12 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024

13 May 2024

15:05 AGM Announcements DE

Heidelberg Pharma AG

AGM Announcements
DE

Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 20.06.2024 in Ladenburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

25 April 2024

07:21 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024

17 April 2024

09:24 Directors’ Dealings

Heidelberg Pharma AG

Directors’ Dealings

Heidelberg Pharma AG: Walter Miller, buy

5 April 2024

09:30 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma to host R&D Webinar following novel data presented at AACR

27 March 2024

09:01 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101

26 March 2024

16:11 Directors’ Dealings

Heidelberg Pharma AG

Directors’ Dealings

Heidelberg Pharma AG: Dr. Georg F. Baur, buy

25 March 2024

07:10 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma announces financial figures and reports on successful business performance in 2023

19 March 2024

09:47 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty

18 March 2024

07:25 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study

6 March 2024

07:46 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024

4 March 2024

11:19 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million

11:02 Ad-hoc

Heidelberg Pharma AG

Ad-hoc

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million

31 January 2024

17:45 Directors’ Dealings DE

Heidelberg Pharma AG

Directors’ Dealings
DE

Heidelberg Pharma AG: Walter Miller, Annahme der Gewährung von 60.000 Aktienoptionen im Rahmen des Aktienoptionsprogramms 2023 für Mitarbeiter und Vorstandsmitglieder der Heidelberg Pharma AG. …

17:38 Directors’ Dealings DE

Heidelberg Pharma AG

Directors’ Dealings
DE

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Annahme der Gewährung von 60.000 Aktienoptionen im Rahmen des Aktienoptionsprogramms 2023 für Mitarbeiter und Vorstandsmitglieder der Heidelberg …

17:27 Directors’ Dealings DE

Heidelberg Pharma AG

Directors’ Dealings
DE

Heidelberg Pharma AG: Dr. Jan Schmidt-Brand, Annahme der Gewährung von 60.000 Aktienoptionen im Rahmen des Aktienoptionsprogramms 2023 für Mitarbeiter und Vorstandsmitglieder der Heidelberg …

22 January 2024

09:42 Advance Financial Reports

Heidelberg Pharma AG

Advance Financial Reports

 

18 December 2023

11:20 Directors’ Dealings

Heidelberg Pharma AG

Directors’ Dealings

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, buy

29 November 2023

12:05 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma AG: Heidelberg Pharma Announces Changes to the Executive Management Board

11:56 Ad-hoc

Heidelberg Pharma AG

Ad-hoc

Heidelberg Pharma AG: Heidelberg Pharma Announces Changes to the Executive Management Board

15 November 2023

09:24 Corporate

Heidelberg Pharma AG

Corporate

Heidelberg Pharma Secures Patent for the Use of its ADC Technology Platform

Upcoming Events

10

Oct 24

Heidelberg Pharma AG

Publication quarterly statement (call-date Q3)

Ladenburg